Recent Updates
Recently added Catalysts
NTHI Positive Sentiment

A Nose For Attacking Brain Cancer

Key Takeaway: NeOnc Technologies' CEO, Dr. Thomas Chen, discussed the company's innovative approach to treating brain cancer on the Bio Report Podcast. The firm utilizes a natural compound from essential oils that can cross the blood-brain barrier and kill cancer cells. This method also allows for the delivery of additional therapies, addressing a significant challenge in brain cancer treatment.

Market Sentiment Analysis

POSITIVE FACTORS

  • NeOnc's approach can potentially improve brain cancer treatment.
  • The compound can cross the blood-brain barrier effectively.
  • It can transport other therapies alongside its own.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~1 mo
High dilution risk
Lead asset
Perillyl alcohol
Phase 1 · Glioblastoma Multiforme

Full Press Release Details

Publication Date: February 5, 2025 Published By: The Bio Report Podcast Article Link: https://open.spotify.com/episode/0raRIZm6OicjYXtrZSLdq9
NeOnc’s CEO and CSO Dr. Thomas Chen sat down for an interview on the Bio Report Podcast. The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
“One of the challenges in treating brain cancer and other diseases of the central nervous system is delivering therapeutics beyond the blood-brain barrier.” said host Daniel Levine, “NeOnc Technologies using a natural compound derived from essential oils in plants that not only can kill cancer cells, but can cross the blood-brain barrier. What’s more, it can transport other therapies as well. We spoke to Thomas Chen, founder and CEO of NeOnc, about brain cancer, how the blood-brain barrier complicates the delivery of therapies to treat the condition, and how its experimental candidate that is delivered intranasally works.”

Frequently Asked Questions

What is NeOnc's approach to treating brain cancer?

NeOnc uses a natural compound from essential oils that can kill cancer cells and cross the blood-brain barrier.

How does the compound help in therapy delivery?

It not only targets cancer cells but also transports other therapies effectively.

Who is the CEO of NeOnc Technologies?

Dr. Thomas Chen is the founder and CEO of NeOnc Technologies.

What challenge does the blood-brain barrier pose?

The blood-brain barrier complicates the delivery of therapeutics for brain cancer.

Last updated: Feb 5, 2025